RRRobert Matthias Radke

Robert Matthias Radke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert Matthias Radke has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Gerhard-Paul Diller

    Clinic for Cardiology III, University Hospital Münster, Münster, Germany

    7 shared publications
  • Helmut Baumgartner

    Department of Cardiology III—Adult Congenital and Valvular Heart Disease, University Hospital Muenster , Albert-Schweitzer-Campus 1, Building A1, Muenster 48149

    7 shared publications
  • Gerrit Kaleschke

    Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, 48149 Muenster, Germany

    5 shared publications
  • Stefan Orwat

    Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Muenster, 48149 Muenster, Germany

    5 shared publications
  • Gerhard-Paul Diller

    Department of Cardiology III - Adult Congenital and Valvular Heart Disease University Hospital Muenster, Germany

    4 shared publications
  • Helmut Baumgartner

    Department of Cardiology III - Adult Congenital and Valvular Heart Disease University Hospital Muenster, Germany

    4 shared publications

Latest Publications

  • Open Access

    Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events

    by Alicia Jeanette Friedrich, Robert Radke, Stefan Orwat, Gerrit Kaleschke, Philipp Darius Garthe, Fernando de Torres-Alba, Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard-Paul Diller, et al.


  • Open Access

    A multi-query, multimodal, receiver-augmented solution to extract contemporary cardiology guideline information using large language models

    by Robert M Radke, Gerhard-Paul Diller, Rohan G Reddy, Pushpa Shivaram, David A Danford, Shelby Kutty

    Aims: The aim of the current study was to assess the utility of a state-of-the-art large language model (LLM) based on curated, defined clinical practice recommendations to support clinicians in obtaining point-of-care guidelines for individual patient treatment while maintaining transparency. Methods and results: We combined cloud-based and locally run LLMs with versatile open-source tools to form a multi-query, multimodal, retrieval-augmented generation chain that closely reflects European cardiology guidelines in its responses. We compared the performance of this generation chain to other LLMs including GPT-3.5 and GPT-4 on a 306-question multiple-choice exam with questions consisting of short patient vignettes from various cardiology subspecialties, originally written to prepare candidates for the European Exam in Core Cardiology. On the multiple-choice test, our system demonstrated overall accuracy of 73.53%, while GPT-3.5 and GPT-4 had overall accuracies of 44.03 and 62.26%, respectively. Our system outperformed GPT-3.5 and GPT-4 for the following categories of questions: coronary artery disease, arrhythmia, other, valvular heart disease, cardiomyopathies, endocarditis, adult congenital heart disease, pericardial disease, cardio-oncology, pulmonary hypertension, and non-cardiac surgery. For maximum transparency, the system also provided reference quotes for its recommendations. Conclusion: Our system demonstrated superior performance in question-answering tasks on a set of core cardiology questions as compared with contemporary publicly available chat models. The current study illustrates that LLMs can be tailored to provide documented and accountable guideline recommendations towards actual clinical needs while ensuring recommendations are derived from up-to-date, trustable, and traceable documents.


  • Open Access

    Utility of Coronary Computed Tomography Angiography in Patients Undergoing Transcatheter Aortic Valve Implantation: A Meta-Analysis and Meta-Regression Based on Published Data from 7458 Patients

    by Gerhard-Paul Diller, Mirjam Gerwing, Simona Boroni Grazioli, Fernando De-Torres-Alba, Robert M. Radke, Julia Vormbrock, Helmut Baumgartner, Gerrit Kaleschke, Stefan Orwat

    Background: Coronary CT angiography (CCTA) may detect coronary artery disease (CAD) in transcatheter aortic valve implantation (TAVI) patients and may obviate invasive coronary angiography (ICA) in selected patients. We assessed the diagnostic accuracy of CCTA for detecting CAD in TAVI patients based on published data. Methods: Meta-analysis and meta-regression were performed based on a comprehensive electronic search, including relevant studies assessing the diagnostic accuracy of CCTA in the setting of TAVI patients compared to ICA. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), were calculated on a patient and per segment level. Results: Overall, 27 studies (total of 7458 patients) were included. On the patient level, the CCTA’s pooled sensitivity and NPV were 95% (95% CI: 93–97%) and 97% (95% CI: 95–98%), respectively, while the specificity and PPV were at 73% (95% CI: 62–82%) and 64% (95% CI: 57–71%), respectively. On the segmental coronary vessel level, the sensitivity and NPV were 90% (95% CI: 79–96%) and 98% (95% CI: 97–99%). Conclusions: This meta-analysis highlights CCTA’s potential as a first-line diagnostic tool although its limited PPV and specificity may pose challenges when interpreting heavily calcified arteries. This study underscores the need for further research and protocol standardization in this area.


  • Immunodeficiency is prevalent in congenital heart disease and associated with increased risk of emergency admissions and death

    by Gerhard-Paul Diller, Astrid Elisabeth Lammers, Alicia Fischer, Stefan Orwat, Klara Nienhaus, Renate Schmidt, Robert M Radke, Fernando De-Torres-Alba, Gerrit Kaleschke, Ursula Marschall, et al.

    Aims: To provide population-based data on the prevalence and clinical significance of immune deficiency syndromes (IDS) associated with congenital heart disease (CHD). Methods and results: Utilizing administrative German Health System data the prevalence of increased susceptibility to infection (ISI) or confirmed IDS was assessed in CHD patients and compared with an age-matched non-congenital control group. Furthermore, the prognostic significance of IDS was assessed using all-cause mortality and freedom from emergency hospital admission. A total of 54 449 CHD patients were included. Of these 14 998 (27.5%) had ISI and 3034 (5.6%) had a documented IDS (compared with 2.9% of the age-matched general population). During an observation period of 394 289 patient-years, 3824 CHD patients died, and 31 017 patients experienced a combined event of all-cause mortality or emergency admission. On multivariable Cox proportional-hazard analysis, the presence of ISI [hazard ratio (HR): 2.14, P < 0.001] or documented IDS (HR: 1.77, P = 0.035) emerged as independent predictors of all-cause mortality. In addition, ISI and confirmed IDS were associated with a significantly higher risk of emergency hospital admission (P = 0.01 for both on competing risk analysis) during follow-up. Conclusion: Limited immune competence is common in CHD patients and associated with an increased risk of morbidity and mortality. This highlights the need for structured IDS screening and collaboration with immunology specialists as immunodeficiency may be amenable to specific therapy. Furthermore, studies are required to assess whether IDS patients might benefit from intensified antibiotic shielding or tailored prophylaxis.


  • Open Access

    Incidence and Predictors of Left Atrial Appendage Thrombus before Catheter Ablation of Thrombogenic Arrhythmias

    by Felix K. Wegner, Robert M. Radke, Christian Ellermann, Julian Wolfes, Kevin Willy, Philipp S. Lange, Gerrit Frommeyer, Helmut Baumgartner, Lars Eckardt, Gerhard-Paul Diller, et al.

    Introduction: Transesophageal echocardiography (TEE) is routinely performed before catheter ablation of atrial tachyarrhythmias to rule out the presence of left atrial thrombi. However, data to support this practice are inconsistent. Methods: We analyzed consecutive pre-procedural TEE in a high-volume electrophysiology center for the presence of left atrial thrombi and a relevant flow reduction in the left atrial appendage (LAA) defined as LAA sludge or LAA emptying velocity (LAAEV) < 20 cm/s. The possible predictors of reduced flow were recorded and compared in a multivariate logistic regression analysis. Results: 1676 TEE were included (1122 before pulmonary vein isolation, 436 before atrial flutter ablation, 166 before other ablations). 543 patients (32%) were female and 991 (59%) were on DOAC. Nine patients (0.5%) had an LAA thrombus on pre-procedural TEE. Ninety-five further patients (5.7%) had a relevant reduction in LAA flow. The underlying rhythm showed a significant association with the presence of LAA thrombus or reduced LAA flow (p = 0.003). Patients in sinus rhythm and cavotricuspid isthmus-dependent atrial flutter exhibited the lowest risk. Additionally, reduced kidney function was associated with a reduction in LAA flow velocities (p = 0.04). Of note, two LAA thrombi occurred in patients in sinus rhythm and six out of nine patients with an LAA thrombus were on vitamin-K antagonists. Conclusions: LAA thrombus is a rare occurrence before an elective catheter ablation. The underlying rhythm and kidney function may serve as markers of a higher likelihood of significantly reduced LAAEV and LAA thrombus.


  • Open Access

    Accuracy of Deep Learning Echocardiographic View Classification in Patients with Congenital or Structural Heart Disease: Importance of Specific Datasets

    by Felix K. Wegner, Maria L. Benesch Vidal, Philipp Niehues, Kevin Willy, Robert M. Radke, Philipp D. Garthe, Lars Eckardt, Helmut Baumgartner, Gerhard-Paul Diller, Stefan Orwat

    Introduction: Automated echocardiography image interpretation has the potential to transform clinical practice. However, neural networks developed in general cohorts may underperform in the setting of altered cardiac anatomy. Methods: Consecutive echocardiographic studies of patients with congenital or structural heart disease (C/SHD) were used to validate an existing convolutional neural network trained on 14,035 echocardiograms for automated view classification. In addition, a new convolutional neural network for view classification was trained and tested specifically in patients with C/SHD. Results: Overall, 9793 imaging files from 262 patients with C/SHD (mean age 49 years, 60% male) and 62 normal controls (mean age 45 years, 50.0% male) were included. Congenital diagnoses included among others, tetralogy of Fallot (30), Ebstein anomaly (18) and transposition of the great arteries (TGA, 48). Assessing correct view classification based on 284,250 individual frames revealed that the non-congenital model had an overall accuracy of 48.3% for correct view classification in patients with C/SHD compared to 66.7% in patients without cardiac disease. Our newly trained convolutional network for echocardiographic view detection based on over 139,910 frames and tested on 35,614 frames from C/SHD patients achieved an accuracy of 76.1% in detecting the correct echocardiographic view. Conclusions: The current study is the first to validate view classification by neural networks in C/SHD patients. While generic models have acceptable accuracy in general cardiology patients, the quality of image classification is only modest in patients with C/SHD. In contrast, our model trained in C/SHD achieved a considerably increased accuracy in this particular cohort.


  • Open Access

    Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis

    by Astrid Elisabeth Lammers, Gerhard-Paul Diller, Rieke Lober, Mareike Möllers, Renate Schmidt, Robert M Radke, Fernando De-Torres-Alba, Gerrit Kaleschke, Ursula Marschall, Ulrike M Bauer, et al.

    The aim of this study was to provide population-based data on maternal and neonatal complications and outcome in the pregnancies of women with congenital heart disease (CHD). Based on administrative data from one of the largest German Health Insurance Companies (BARMER GEK, ∼9 million members representative for Germany), all pregnancies in women with CHD between 2005 and 2018 were analysed. In addition, an age-matched non-CHD control group was included for comparison and the association between adult CHD (ACHD) and maternal or neonatal outcomes investigated. Overall, 7512 pregnancies occurred in 4015 women with CHD. The matched non-CHD control group included 6502 women with 11 225 pregnancies. Caesarean deliveries were more common in CHD patients (40.5% vs. 31.5% in the control group; P < 0.001). There was no excess mortality. Although the maternal complication rate was low in absolute terms, women with CHD had a significantly higher rate of stroke, heart failure and cardiac arrhythmias during pregnancy (P < 0.001 for all). Neonatal mortality was low but also significantly higher in the ACHD group (0.83% vs. 0.22%; P = 0.001) and neonates to CHD mothers had low/extremely low birth weight or extreme immaturity (<0.001) or required resuscitation and mechanical ventilation more often compared to non-CHD offspring (P < 0.001 for both). On multivariate logistic regression maternal defect complexity, arterial hypertension, heart failure, prior fertility treatment, and anticoagulation with vitamin K antagonists emerged as significant predictors of adverse neonatal outcome (P < 0.05 for all). Recurrence of CHD was 6.1 times higher in infants to ACHD mothers compared to controls (P < 0.0001). This population-based study illustrates a reassuringly low maternal mortality rate in a highly developed healthcare system. Nevertheless, maternal morbidity and neonatal morbidity/mortality were significantly increased in women with ACHD and their offspring compared to non-ACHD controls highlighting the need of specialized care and pre-pregnancy counselling. Overview over the main findings of the study. The results illustrate significantly increased risk of maternal and neonatal complications as well as a significantly increased risk of recurrence of congenital heart disease in the children of congenital heart disease mothers. For details, please see Tables 1–4.


  • Infektiöse Endokarditis bei Erwachsenen mit angeborenen Herzfehlern

    by Maarja Maser, Robert Matthias Radke

    Erwachsene Patienten mit angeborenen Herzfehlern (EMAH) sind eine größer werdende Patientengruppe, die eine lebenslange Begleitung und Behandlung benötigt. Eine der wichtigsten Komplikationen bei EMAH-Patienten ist die infektiöse Endokarditis. Die Echokardiografie hat sowohl bei der Diagnosesicherung als auch beim Erkennen von Komplikationen und im Follow-up eine ganz zentrale Bedeutung. Computer- und Positronenemissionstomografie werden zur Beurteilung von implantierten Fremdmaterial zunehmend eingesetzt. Eine antibiotische Therapie erfolgt zunächst empirisch und später auf den individuellen Erreger zugeschnitten. Zurzeit wird die Antibiotikaprophylaxe nur den Patienten mit deutlich erhöhtem Endokarditisrisiko vor den zahnärztlichen Eingriffen mit dem höchsten Risiko empfohlen. Adults with congenital heart disease (ACHD) are a growing group of patients that require lifelong follow-up and treatment. One of the main complications is infective endocarditis. Echocardiography is the main diagnostic modality to confirm the diagnosis of infective endocarditis as well as to detect the possible complications. CT and PET-CT are helpful to assess foreign materials such as valve prosthesis. Initial broad antibiotic therapy will be started and later adapted according to the microorganisms detected in the blood cultures. Antibiotic prophylaxis is recommended only to the patients with cardiac conditions at highest risk of infective endocarditis undergoing high-risk dental procedures. Publication Date: 11 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Incidence of left atrial appendage thrombus on pre-procedural TOE before catheter ablation of atrial tachyarrhythmias

    by F Wegner, R Radke, C Ellermann, J Wolfes, A.J Fischer, H Baumgartner, L Eckardt, G.P Diller, S Orwat

    Transoesophageal echocardiography (TOE) is routinely performed before catheter ablation of atrial tachyarrhythmias to rule out the presence of possible left atrial thrombi. However, data to support this practice are scarce. We analysed consecutive pre-procedural TOE in a high-volume electrophysiology centre for the presence of left atrial thrombi and a relevant flow reduction in the left atrial appendage (LAA) defined as LAA sludge or pronounced spontaneous echo contrast. Possible predictors of reduced flow were recorded and compared in a multivariate logistic regression analysis. 1676 consecutive TOE were included (1122 before pulmonary vein isolation (PVI), 436 before atrial flutter ablation, 166 before other EP studies in patients with a history of atrial tachyarrhythmias). 543 patients (32%) were female, mean age was 63±12 years and BMI was 27±5 kg/m2. Nine patients (0.5%) had an LAA thrombus on pre-procedural TOE. Ninety-five further patients (5.7%) had a relevant reduction in LAA flow as characterized by LAA sludge or spontaneous echo contrast. Further patient characteristics by LAA flow state are shown in the table. While a higher CHA2DS2-VaSc-Score was associated with the presence of LAA sludge and LAA thrombus (p=0.01), no further clinical parameters such as choice of oral anticoagulation agent were independently predictive of reduced flow velocities or thrombus in a logistic regression model (see table). Importantly, LAA thrombi also occurred in patients with a CHA2DS2-VaSc-Score ≤1 (n=1) or in sinus rhythm (n=2). Of note, 6 out of 9 patients with a LAA thrombus were anticoagulated with phenprocoumon. LAA thrombus is a rare occurrence before an elective catheter ablation. In patients with CHA2DS2-VaSc-Score ≤1 the likelihood of LAA thrombus is so low (0.2%) that it may be considered to give up routine TOE before an EP study/ablation.

  • Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study

    by Gerhard-Paul Diller, Stefan Orwat, Astrid Elisabeth Lammers, Robert M Radke, Fernando De-Torres-Alba, Renate Schmidt, Ursula Marschall, Ulrike M Bauer, Dominic Enders, Leo Bronstein, et al.

    The aim of this study was to provide population-based data on the healthcare provision for adults with congenital heart disease (ACHD) and the impact of cardiology care on morbidity and mortality in this vulnerable population. Based on administrative data from one of the largest German Health Insurance Companies, all insured ACHD patients (P = 0.03) or major events (HR 0.85, 95% CI 0.78–0.92; P < 0.001) compared to those only followed by PCPs. At 3-year follow-up, the absolute risk difference for mortality was 0.9% higher in ACHD patients with moderate/severe complexity lesions cared by PCPs compared to those under cardiology follow-up. Cardiology care compared with primary care is associated with superior survival and lower rates of major complications in ACHD. It is alarming that even in a high resource setting with well-established specialist ACHD care approximately 50% of contemporary ACHD patients are still not linked to regular cardiac care. Almost all patients had at least one contact with a PCP during the study period, suggesting that opportunities to refer patients to cardiac specialists were missed at PCP level. More efforts are required to alert PCPs and patients to appropriate ACHD care. Study design and overview over the main results illustrating the unmet need of regular cardiology follow-up in 50.3% of adult congenital heart disease patients over a 3-year period. Care provided by primary care physicians was associated with worse outcome (mortality and freedom from death or major adverse events) compared to follow-up by cardiac specialists.